These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 19818257

  • 1. Activation induced by high-dose ziprasidone: a case report.
    Kaushik S, Maccabee N, Kaushik S, Lindenmayer JP.
    J Clin Psychiatry; 2009 Sep; 70(9):1326-7. PubMed ID: 19818257
    [No Abstract] [Full Text] [Related]

  • 2. Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?
    Oechsner M, Korchounov A.
    Hum Psychopharmacol; 2005 Apr; 20(3):203-5. PubMed ID: 15799011
    [Abstract] [Full Text] [Related]

  • 3. Acute dystonia, akathisia, and parkinsonism induced by ziprasidone.
    Praharaj SK, Jana AK, Sarkhel S, Sinha VK.
    Am J Ther; 2014 Apr; 21(2):e38-40. PubMed ID: 23698184
    [Abstract] [Full Text] [Related]

  • 4. Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial.
    Daniel DG, Potkin SG, Reeves KR, Swift RH, Harrigan EP.
    Psychopharmacology (Berl); 2001 May; 155(2):128-34. PubMed ID: 11401000
    [Abstract] [Full Text] [Related]

  • 5. Is relapse a justification for the use of high-dose antipsychotics?
    Cohen S, Chiles JA.
    J Clin Psychiatry; 1990 Nov; 51(11):486-7. PubMed ID: 1977741
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ziprasidone-induced tardive dyskinesia in a patient without known risk factors.
    Sinha P, Rao R, Sharan P.
    Natl Med J India; 2007 Nov; 20(5):271-2. PubMed ID: 18254531
    [No Abstract] [Full Text] [Related]

  • 8. Sudden death in a patient with Tourette syndrome during a clinical trial of ziprasidone.
    Scahill L, Blair J, Leckman JF, Martin A.
    J Psychopharmacol; 2005 Mar; 19(2):205-6. PubMed ID: 15728441
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intramuscular ziprasidone treatment of acute psychotic agitation in elderly patients with schizophrenia.
    Barak Y, Mazeh D, Plopski I, Baruch Y.
    Am J Geriatr Psychiatry; 2006 Jul; 14(7):629-33. PubMed ID: 16816018
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
    Ozen ME, Yumru M, Savas HA, Cansel N, Herken H.
    World J Biol Psychiatry; 2007 Jul; 8(1):42-4. PubMed ID: 17366349
    [Abstract] [Full Text] [Related]

  • 19. Ziprasidone-induced acute dystonia.
    Mason MN, Johnson CE, Piasecki M.
    Am J Psychiatry; 2005 Mar; 162(3):625-6. PubMed ID: 15741487
    [No Abstract] [Full Text] [Related]

  • 20. High-dose ziprasidone-induced acute dystonia.
    Rosenfield PJ, Girgis RR, Gil R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar 30; 31(2):546-7. PubMed ID: 17123682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.